Last reviewed · How we verify
NCT04231227
The Validity and Reliability of the Turkish Version of TASC and the Relationship Between SMC and Motor Functions
trial in Cerebral Palsy, Spastic in 36 participants. Completed in 15 June 2019.
30 September 2018
Quick facts
| Lead sponsor | Gazi University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 36 |
| Start date | 1 July 2018 |
| Primary completion | 30 September 2018 |
| Estimated completion | 15 June 2019 |
| Sites | 1 location across Turkey (Türkiye) |
Conditions studied
- Cerebral Palsy, Spastic — all drugs for Cerebral Palsy, Spastic →
- Cerebral Palsy — all drugs for Cerebral Palsy →
- Cerebral Palsy Spastic Diplegia — all drugs for Cerebral Palsy Spastic Diplegia →
- Cerebral Palsy Quadriplegic — all drugs for Cerebral Palsy Quadriplegic →
Sponsor
Gazi University
Who can join
Adults 4 to 18, any sex, with Cerebral Palsy, Spastic or Cerebral Palsy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Selective motor control (SMC) impairment in children with cerebral palsy (CP) includes movement patterns dominated by flexor or extensor synergy affecting functional movements. The research was designed to investigate the validity and the reliability of the Turkish version of the Test of Arm Selective Control (TASC) (which is improved to evaluate SMC in children with spastic CP) and in order to provide more understanding of the relationship between SMC and upper extremity and gross motor functions. The study included 21 hemiplegic, 11 diplegic and 4 quadriplegic children with CP whose ages are 4 to 18 years and Gross Motor Function Classification System (GMFCS) level changes from 1 to 4, and their parents. In order to evaluate the gross motor function of children, GMFCS and the ability to hold objects with their hands in daily activities were evaluated with Manual Ability Classification System (MACS). ABILHAND-Kids scale was applied to evaluate upper extremity performance. TASC scale was used to evaluate the upper extremity SMC of children.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04231227
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cerebral Palsy, Spastic
Currently open trials in the same condition.
- NCT07118228 — Ultrasonographic Assessment of Muscle Morphology, Function, and Clinical Findings in Spastic Cerebral Palsy · recruiting
- NCT06880887 — Nervus Vagus Stimulation and Cerebral Palsy · Phase 1 · active not recruiting
- NCT06640894 — Power2Walk: The Impact of Functional Power Training on Participation and Activity in Children With Cerebral Palsy. · NA · recruiting
- NCT06330922 — Muscle-tendon Pathology and Metabolic Dysregulation in CP · recruiting
- NCT05593887 — Late-presenting Hip Dislocation in Non-ambulatory Children With Cerebral Palsy: A Comparison of Three Procedures · NA · recruiting
Other Gazi University trials
Trials by the same sponsor.
- NCT07500857 — Gamification in Stoma Care Education for Nursing Students · NA · not yet recruiting
- NCT07471737 — Patient Safety and Medical Errors in Nursing Education: Learning by Doing and Experiencing With Simulated Patients · NA · not yet recruiting
- NCT07440563 — Auricular Vagus Nerve Stimulation Combined With Rehabilitation in Parkinson's Disease · NA · enrolling by invitation
- NCT07496398 — Median and Ulnar Nerve Function in Tattoo Artists · recruiting
- NCT07471386 — Adjunctive Keratinized Mucosa Augmentation in Peri-Implantitis · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04231227 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Gazi University
- Last refreshed: 18 January 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04231227.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing